See more : Gerdau S.A. (GGB) Income Statement Analysis – Financial Results
Complete financial analysis of Sharecare, Inc. (SHCRW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sharecare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- OncoCyte Corporation (0KCC.L) Income Statement Analysis – Financial Results
- Henderson Opportunities Trust plc (HOT.L) Income Statement Analysis – Financial Results
- Parabellum Resources Limited (PBL.AX) Income Statement Analysis – Financial Results
- Metalert, Inc. (GTXO) Income Statement Analysis – Financial Results
- Pegasus Tel, Inc. (PTEL) Income Statement Analysis – Financial Results
Sharecare, Inc. (SHCRW)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: http://www.sharecare.com
About Sharecare, Inc.
Sharecare, Inc. is a digital healthcare company engaged in unifying elements of individual and community health into one experience. It is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. The company was founded by Jeffrey T. Arnold in 2009 and is headquartered in Atlanta, GA.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 445.25M | 442.42M | 412.82M | 328.81M | 339.54M | 341.87M |
| Cost of Revenue | 315.75M | 238.29M | 203.22M | 160.91M | 179.97M | 192.15M |
| Gross Profit | 129.50M | 204.12M | 209.60M | 167.89M | 159.57M | 149.72M |
| Gross Profit Ratio | 29.08% | 46.14% | 50.77% | 51.06% | 47.00% | 43.79% |
| Research & Development | 70.05M | 70.53M | 74.44M | 44.08M | 45.86M | 51.42M |
| General & Administrative | 138.01M | 171.81M | 136.59M | 83.24M | 65.82M | 61.36M |
| Selling & Marketing | 57.42M | 55.87M | 51.41M | 33.34M | 33.99M | 34.60M |
| SG&A | 155.93M | 227.68M | 188.00M | 116.57M | 99.82M | 105.97M |
| Other Expenses | -2.30M | 45.26M | 32.60M | 24.68M | 23.78M | 0.00 |
| Operating Expenses | 225.97M | 343.46M | 295.04M | 185.34M | 169.45M | 179.37M |
| Cost & Expenses | 541.73M | 581.76M | 498.26M | 346.25M | 349.42M | 371.51M |
| Interest Income | 6.30M | 1.87M | 96.00K | 71.00K | 149.00K | 25.25M |
| Interest Expense | 1.76M | 2.43M | 27.66M | 31.04M | 28.69M | 0.00 |
| Depreciation & Amortization | 61.21M | 51.17M | 32.60M | 24.68M | 23.78M | 19.65M |
| EBITDA | -67.25M | -66.09M | -26.89M | -2.39M | 13.24M | -7.66M |
| EBITDA Ratio | -7.92% | -16.28% | -6.23% | 2.21% | 4.07% | -2.24% |
| Operating Income | -96.48M | -139.34M | -85.44M | -17.43M | -9.97M | -27.32M |
| Operating Income Ratio | -21.67% | -31.50% | -20.70% | -5.30% | -2.94% | -7.99% |
| Total Other Income/Expenses | 5.75M | 19.65M | -1.71M | -40.68M | -29.34M | -27.58M |
| Income Before Tax | -130.22M | -119.69M | -87.15M | -58.12M | -39.22M | -54.90M |
| Income Before Tax Ratio | -29.25% | -27.05% | -21.11% | -17.67% | -11.55% | -16.06% |
| Income Tax Expense | -209.00K | -206.00K | -2.02M | -1.56M | 213.00K | 94.00K |
| Net Income | -128.50M | -119.49M | -85.13M | -56.56M | -39.44M | -55.93M |
| Net Income Ratio | -28.86% | -27.01% | -20.62% | -17.20% | -11.61% | -16.36% |
| EPS | -0.36 | -0.34 | -0.30 | -0.26 | -0.12 | -29.53 |
| EPS Diluted | -0.36 | -0.34 | -0.30 | -0.26 | -0.12 | -29.53 |
| Weighted Avg Shares Out | 352.08M | 348.10M | 281.03M | 217.11M | 333.90M | 1.89M |
| Weighted Avg Shares Out (Dil) | 352.08M | 348.10M | 281.03M | 217.11M | 333.90M | 1.89M |
Source: https://incomestatements.info
Category: Stock Reports